Cost-effectiveness and Net Monetary Benefit of durvalumab...

  • Main
  • 2020 / 4
  • Cost-effectiveness and Net Monetary Benefit of durvalumab...
Clinical Therapeutics 2020 / 4

Cost-effectiveness and Net Monetary Benefit of durvalumab Consolidation Therapy Versus No Consolidation Therapy After Chemoradiotherapy in Stage III Non–small Cell Lung Cancer in the Italian National Health Service

Armeni, Patrizio, Borsoi, Ludovica, Fornaro, Giulia, Jommi, Claudio, Grossi, Francesco, Costa, Francesco
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Clinical Therapeutics
DOI:
10.1016/j.clinthera.2020.03.012
Date:
April, 2020
File:
PDF, 1.77 MB
2020
Conversion to is in progress
Conversion to is failed